EUDA logo

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) trades at $10.56 with AI Score 46/100 (Weak). EUDA Health Holdings Limited operates a digital health platform, providing virtual consultations for non-emergency medical needs. Market cap: 20M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
EUDA Health Holdings Limited operates a digital health platform, providing virtual consultations for non-emergency medical needs. Founded in 2019 and based in Singapore, EUDA aims to improve healthcare accessibility through technology.
46/100 AI Score Target $6.00 (-43.2%) MCap 20M Vol 4K

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) Healthcare & Pipeline Overview

CEOAlfred Lim
Employees117
HeadquartersSingapore, SG
IPO Year2021

EUDA Health Holdings pioneers accessible healthcare through its digital platform, offering virtual consultations for non-emergency medical issues. With a focus on the Southeast Asian market, EUDA leverages technology to bridge healthcare gaps and enhance patient convenience, positioning itself for growth in the evolving telehealth landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

EUDA Health presents a notable research candidate due to its strategic positioning in the rapidly growing telehealth market. With a market capitalization of $0.04 billion and a P/E ratio of 154.67, EUDA demonstrates potential for growth as it expands its digital health platform. The company's focus on virtual consultations for non-emergency medical issues addresses a critical need for accessible healthcare solutions, particularly in Southeast Asia. Key value drivers include increasing user adoption of telehealth services, strategic partnerships with healthcare providers, and expansion into new geographic markets. The company's 5.2% profit margin indicates operational efficiency, while its negative beta of -0.15 suggests lower volatility compared to the overall market. Upcoming catalysts include platform enhancements and expansion into new service offerings.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.04B indicates the company's current valuation in the market.
  • P/E Ratio of 154.67 suggests investors are willing to pay a premium for each dollar of earnings, reflecting growth expectations.
  • Profit Margin of 5.2% demonstrates the company's ability to generate profit from its revenue.
  • Gross Margin of 22.4% reflects the efficiency of EUDA's service delivery and cost management.
  • Beta of -0.15 indicates that the stock price is less volatile than the overall market, offering stability to investors.

Competitors & Peers

Strengths

  • Digital health platform providing convenient virtual consultations.
  • Focus on the growing Southeast Asian market.
  • Subsidiary of Watermark Developments Limited, providing financial backing.
  • Relatively low Beta indicates lower volatility.

Weaknesses

  • Limited operating history since founded in 2019.
  • Small market capitalization of $0.04B.
  • High P/E ratio of 154.67 may indicate overvaluation.
  • Gross margin of 22.4% is relatively low.

Catalysts

  • Upcoming: Platform enhancements to improve user experience and functionality.
  • Ongoing: Expansion into new geographic markets within Southeast Asia.
  • Ongoing: Strategic partnerships with healthcare providers to broaden service reach.

Risks

  • Potential: Competition from larger, more established telehealth providers.
  • Potential: Regulatory changes impacting the telehealth industry.
  • Potential: Cybersecurity breaches compromising patient data.
  • Ongoing: Dependence on Watermark Developments Limited for financial support.
  • Ongoing: Negative publicity impacting brand reputation.

Growth Opportunities

  • Expansion into New Geographic Markets: EUDA has the opportunity to expand its services into additional Southeast Asian countries, tapping into a larger pool of potential users. The Southeast Asian telehealth market is projected to experience significant growth, driven by increasing internet penetration and rising healthcare awareness. By establishing partnerships with local healthcare providers and adapting its platform to meet the specific needs of each market, EUDA can drive user adoption and revenue growth. Timeline: Within the next 2-3 years.
  • Enhancement of Service Offerings: EUDA can enhance its platform by incorporating additional services such as remote patient monitoring, chronic disease management, and mental health support. These value-added services can attract new users and increase engagement among existing users, driving revenue growth and strengthening EUDA's competitive position. The market for remote patient monitoring is expected to grow substantially as healthcare providers seek to improve patient outcomes and reduce costs. Timeline: Ongoing.
  • Strategic Partnerships with Healthcare Providers: EUDA can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its virtual consultation services into their existing workflows. These partnerships can provide EUDA with access to a broader patient base and enhance its credibility within the healthcare community. The healthcare industry is increasingly embracing digital health solutions, creating opportunities for collaboration and innovation. Timeline: Ongoing.
  • Leveraging AI and Data Analytics: EUDA can leverage artificial intelligence (AI) and data analytics to improve the efficiency and effectiveness of its virtual consultation services. AI-powered tools can assist with tasks such as appointment scheduling, preliminary diagnosis, and personalized treatment recommendations. By analyzing patient data, EUDA can identify trends and patterns to optimize its service offerings and improve patient outcomes. The market for AI in healthcare is rapidly growing, driven by the potential to improve efficiency and reduce costs. Timeline: Within the next 1-2 years.
  • Development of Mobile Health Applications: EUDA can develop mobile health applications to provide patients with convenient access to its virtual consultation services on their smartphones and tablets. Mobile health apps can enhance user engagement and improve patient adherence to treatment plans. The mobile health market is experiencing rapid growth, driven by the increasing adoption of smartphones and the growing demand for convenient healthcare solutions. Timeline: Within the next year.

Opportunities

  • Expansion into new geographic markets within Southeast Asia.
  • Enhancement of service offerings to include remote patient monitoring.
  • Strategic partnerships with healthcare providers.
  • Leveraging AI and data analytics to improve service efficiency.

Threats

  • Competition from larger telehealth providers like Amwell.
  • Regulatory changes in the healthcare industry.
  • Cybersecurity risks associated with digital health platforms.
  • Economic downturns affecting healthcare spending.

Competitive Advantages

  • Proprietary digital health platform that facilitates virtual consultations.
  • Established network of healthcare professionals and specialists.
  • Focus on the Southeast Asian market, providing a regional advantage.

About EUDA

EUDA Health Holdings Limited, established in 2019 and headquartered in Singapore, is a digital health company focused on providing virtual consultation services. Recognizing the increasing demand for accessible and convenient healthcare solutions, EUDA developed a platform that connects patients with healthcare professionals for non-emergency medical issues. As a subsidiary of Watermark Developments Limited, EUDA benefits from strategic support and resources to expand its reach and enhance its technological capabilities. The company's core offering revolves around its digital health platform, which enables patients to receive virtual consultations from qualified doctors and specialists. This service is particularly valuable for individuals seeking quick medical advice, prescription refills, or preliminary diagnoses without the need for in-person visits. EUDA's platform is designed to be user-friendly and accessible, catering to a diverse range of patients with varying levels of technological proficiency. EUDA's geographic focus is primarily on the Southeast Asian market, where there is a significant need for improved healthcare infrastructure and accessibility. By leveraging technology, EUDA aims to bridge the gaps in healthcare delivery and provide convenient, affordable solutions to patients in the region. The company's competitive positioning is centered on its ability to offer a seamless virtual consultation experience, leveraging its technology platform and network of healthcare professionals.

What They Do

  • Provides virtual consultations for non-emergency medical issues.
  • Connects patients with qualified doctors and specialists through a digital platform.
  • Offers convenient access to healthcare services without the need for in-person visits.
  • Facilitates prescription refills and preliminary diagnoses online.
  • Focuses on improving healthcare accessibility in Southeast Asia.
  • Operates as a subsidiary of Watermark Developments Limited.

Business Model

  • Generates revenue through fees charged for virtual consultations.
  • Partners with healthcare providers to expand its service offerings.
  • Leverages technology to provide efficient and cost-effective healthcare solutions.

Industry Context

EUDA Health operates within the rapidly expanding telehealth market, driven by increasing demand for remote healthcare solutions and technological advancements. The global telehealth market is projected to reach billions of dollars in the coming years, fueled by factors such as aging populations, rising healthcare costs, and the need for convenient access to medical services. EUDA competes with other telehealth providers like AMWL (Amwell) and DTIL (DTI). EUDA's focus on Southeast Asia positions it to capitalize on the region's growing healthcare needs and increasing adoption of digital health technologies.

Key Customers

  • Individuals seeking quick medical advice for non-emergency issues.
  • Patients requiring prescription refills or preliminary diagnoses.
  • People in Southeast Asia with limited access to traditional healthcare services.
AI Confidence: 70% Updated: Feb 8, 2026

Financials

Chart & Info

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) stock price: $10.56 (-0.34, -3.09%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EUDA.

Price Targets

Consensus target: $6.00

MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates EUDA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA)

What does EUDA Health Holdings Limited do?

EUDA Health Holdings Limited operates a digital health platform that provides virtual consultations for non-emergency medical issues. The company connects patients with qualified doctors and specialists through its platform, offering convenient access to healthcare services without the need for in-person visits. EUDA primarily focuses on the Southeast Asian market, aiming to improve healthcare accessibility and affordability in the region. The company generates revenue through fees charged for virtual consultations and partnerships with healthcare providers.

Is EUDA stock worth researching?

EUDA Health Holdings presents a mixed investment profile. Its strategic focus on the growing telehealth market in Southeast Asia and its innovative digital platform are positive factors. However, the company's small market capitalization of $0.04 billion and high P/E ratio of 154.67 suggest potential overvaluation. Investors should carefully consider the company's growth potential, competitive landscape, and financial metrics before making an investment decision. The company's negative Beta may appeal to investors seeking stability.

What are the main risks for EUDA?

EUDA Health Holdings faces several risks, including competition from larger telehealth providers with greater resources and brand recognition. Regulatory changes in the healthcare industry could also impact the company's operations and profitability. Cybersecurity breaches pose a significant threat to patient data and the company's reputation. Additionally, EUDA's dependence on Watermark Developments Limited for financial support could limit its ability to pursue growth opportunities independently. Economic downturns could affect healthcare spending and reduce demand for EUDA's services.

What are the key factors to evaluate for EUDA?

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) currently holds an AI score of 46/100, indicating low score. The stock trades at a P/E of 79.7x, above the S&P 500 average (~20-25x), suggesting high growth expectations. Analysts target $6.00 (-43% from $10.56). Key strength: Digital health platform providing convenient virtual consultations.. Primary risk to monitor: Potential: Competition from larger, more established telehealth providers.. This is not financial advice.

How frequently does EUDA data refresh on this page?

EUDA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven EUDA's recent stock price performance?

Recent price movement in EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $6.00 implies 43% downside from here. Notable catalyst: Digital health platform providing convenient virtual consultations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider EUDA overvalued or undervalued right now?

Determining whether EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 79.7. Analysts target $6.00 (-43% from current price), suggesting analysts see downside risk. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying EUDA?

Before investing in EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on limited available data.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks